Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155296 | SCV000204982 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Met319Ile in Exon 10 of TMPRSS3: This variant is not expected to have clinical s ignificance because it has been identified in 0.6% (23/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs115223836). |
Gene |
RCV000907877 | SCV000718117 | likely benign | not provided | 2021-04-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000907877 | SCV001052606 | benign | not provided | 2024-12-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003162632 | SCV003886520 | uncertain significance | Inborn genetic diseases | 2023-02-09 | criteria provided, single submitter | clinical testing | The c.957G>C (p.M319I) alteration is located in exon 10 (coding exon 9) of the TMPRSS3 gene. This alteration results from a G to C substitution at nucleotide position 957, causing the methionine (M) at amino acid position 319 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |